Tags |
|
|
Links |
|
|
Advice You - Is the Domain Name Market Heading for a Deadfall?
If you ever registered a domain name and tried to re-sell it, you will know the agony of making a successful, profitable sale. The domain name game is
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
not easy, and in fact it is quite challenging to any beginner. Many domain name investors are coming to the conclusion that the market is flooded wit
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
domain names, and there is just way more sellers than there is buyers. Now this may seem dreadful, but it’s not time to take a slap in the face just
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
et.
You see, the truth is that the market is flooded with “worthless” names that domain rookies registered and are trying to resell. Inexperienced do
You see, the truth is that the market is flooded with “worthless” names that domain rookies registered and are trying to resell. Inexperienced do
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ain name investors do not buy from other re-sellers; they just stick to registering domains at the lowest possible fee. What we begin to see is masses
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
of worthless domains, and no buyers. The only one who is making money off this is domain name registration companies. Now, lets explore why the experi
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
nced domain name investor is unaffected by this “flood” of worthless domains.
First of all, knowledgeable domain name investors buy domains from othe
First of all, knowledgeable domain name investors buy domains from othe
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
investors. If they see a good domain being auctioned off extremely under priced, they go for the kill. They know that they have a good domain name on
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
their hands and they hold on to it, even if it takes several years to make a sale. You must be able to sort the “gold” from the “dirt”. Rookie domain
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ame investors cannot wait more that one year; they usually seek a quick buck and register domains that are not worth anything causing a flood on the m
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
rket. Since the average domain which has some value to it takes approximately 12 months to sell, the investor who does not know the true value of his
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
omain will end up letting the domain name expire at the end of the year. This causes the flood to “evaporate” and only the good domains are left behin
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
in the hands of serious investors.
The experienced investor is not affected by the mass of domains available on the market since they will all disap
The experienced investor is not affected by the mass of domains available on the market since they will all disap
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ear very soon. Good domains are always selling, and bad ones are just left to expire and written off as a loss. If the domains would not expire, but w
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
uld be left to sit on the market forever, we would have a huge problem on our hands. So there is actually a benefit to the yearly fee that we all have
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
to pay in order to participate in this exciting investment revolution. The domain name market is no where near collapsing since the internet growing e
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ponentially. Millions of new internet users are joining the world network each year, generating more traffic and more revenue onto the virtual marketp
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ace.
Be wise. Don’t fall for the “quick buck” scheme. The flooded domain market only shows us that there are huge numbers of people trying to get ric
Be wise. Don’t fall for the “quick buck” scheme. The flooded domain market only shows us that there are huge numbers of people trying to get ric
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
without putting in much effort. These folks are heading for a sad downfall since the opportunity which they are looking for today already past us mor
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
than ten years ago when the market was first emerging. If you take your time and keep your cool when engaging on the marketplace, you will make money
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/59455/adviceyou-Is-the-Domain-Name-Market-Heading-for-a-Deadfall.html">Is the Domain Name Market Heading for a Deadfall?</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/59455/adviceyou-Is-the-Domain-Name-Market-Heading-for-a-Deadfall.html]Is the Domain Name Market Heading for a Deadfall?[/url]
Related Articles:
Truths for Introverts Who Sell: What We Don't Need To Learn The Extroverted Hard Way – Part Four
Bookmark it:
|